Literature DB >> 7453832

Interneurones are probably not involved in the presynaptic dopaminergic control of dopamine release in rabbit caudate nucleus.

R Jackisch, A Zumstein, G Hertting, K Starke.   

Abstract

Slices of rabbit caudate nucleus were preincubated with 3H-dopamine and then superfused. The influence of apomorphine and haloperidol on the overflow of tritium evoked by 20 mmol/l potassium was investigated in the presence and in the absence of tetrodotoxin. The potassium-evoked overflow was largely calcium-dependent and consisted mainly of 3H-dopamine. The dopamine receptor agonist apomorphine 0.01-1.0 mumol/l reduced, whereas the antagonist haloperidol 0.1 mumol/l enhanced the potassium-evoked overflow of tritium. The effects of apomorphine and haloperidol were as pronounced in the presence as in the absence of tetrodotoxin 0.3 mumol/l. It is concluded that the presynaptic dopaminergic modulation of dopamine release is not mediated by a tetrodotoxin-sensitive interneuronal pathway.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7453832     DOI: 10.1007/bf00504528

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Effects of l-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices.

Authors:  P J Roberts; N A Sharif
Journal:  Brain Res       Date:  1978-11-24       Impact factor: 3.252

2.  Attempts to localize the GABA receptors involved in the GABA-induced release of newly-synthesized [3H]dopamine in rat striatal slices.

Authors:  M F Giorguieff-Chesselet; M L Kemel; D Wandscheer; J Glowinski
Journal:  Brain Res       Date:  1979-10-19       Impact factor: 3.252

3.  Do presynaptic autoreceptors control dopamine release?

Authors:  M Raiteri; A M Cervoni; R del Carmine; G Levi
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

4.  Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.

Authors:  J C Miller; A J Friedhoff
Journal:  Biochem Pharmacol       Date:  1979-03-01       Impact factor: 5.858

5.  Effects of papaverine on the release and metabolism of dopamine in rat striatum.

Authors:  L Cubeddu; I S Hoffmann; V B Paris
Journal:  J Pharmacol Exp Ther       Date:  1979-04       Impact factor: 4.030

6.  Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.

Authors:  J I Nagy; T Lee; P Seeman; H C Fibiger
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

7.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

8.  Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices.

Authors:  M Göthert; G Weinheimer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

9.  Stimulation by atropine of acetylcholine release and synthesis in cortical slices from rat brain.

Authors:  P C Molenaar; R L Polak
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

10.  Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors:  M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  10 in total

1.  Analysis of cat retina for dopamine, dihydroxyphenylacetic acid, 3-methoxytyramine and homovanillic acid.

Authors:  D M Vaughn; D M Lindley; N R Cox; S T Simpson; W L Whitmer
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

2.  Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.

Authors:  R S Flint; J M Murphy; W J McBride
Journal:  Neurochem Res       Date:  1985-04       Impact factor: 3.996

3.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

4.  Activation of A1 adenosine receptors decreases the release of serotonin in the rabbit hippocampus, but not in the caudate nucleus.

Authors:  T J Feuerstein; K I Bär; C H Lücking
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

5.  The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on potassium-evoked release.

Authors:  R A Gazzara; S L Andersen
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

6.  Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: role of calcium channels and sodium-proton exchange.

Authors:  M Haass; G Richardt; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

7.  Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.

Authors:  J P Herman; A Lupp; N Abrous; M Le Moal; G Hertting; R Jackisch
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

8.  In vitro effect of the racemic mixture and the (-)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor.

Authors:  R Markstein; D Lahaye
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

9.  Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit.

Authors:  G Hertting; A Zumstein; R Jackisch; I Hoffmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

10.  The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium.

Authors:  C L Schönfeld; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.